ACS Medicinal Chemistry Letters
Technology Note
(2) Meunier, B.; de Visser, S. P.; Shaik, S. Mechanism of oxidation
reactions catalyzed by cytochrome P450 enzymes. Chem. Rev. 2004,
104, 3947−3980.
(3) Stachulski, A. V.; Baillie, T. A.; Park, B. K.; Obach, R. S.; Dalvie,
D. K.; Williams, D. P.; Srivastava, A.; Regan, S. L.; Antoine, D. J.;
Goldring, C. E. P.; Chia, A. J. L.; Kitteringham, N. R.; Randle, L. E.;
Callan, H.; Castrejon, J. L.; Farrell, J.; Naisbitt, D. J.; Lennard, M. S.
The generation, detection and effects of reactive drug metabolites.
Med. Res. Rev. 2013, 33, 985−1080.
(4) Baillie, T. A. Metabolism and toxicity of drugs. Two decades of
progress in industrial drug metabolism. Chem. Res. Toxicol. 2008, 21,
129−137.
(5) Johansson, T.; Weidolf, L.; Jurva, U. Mimicry of phase I drug
metabolism: novel methods for metabolite characterization and
synthesis. Rapid Commun. Mass Spectrom. 2007, 21, 2323−2331.
(6) Lohmann, W.; Karst, U. Biomimetic modeling of oxidative drug
metabolism: strategies, advantages and limitations. Anal. Bioanal.
Chem. 2008, 391, 79−96.
(7) Frontana-Uribe, B. A.; Little, R. D.; Ibanez, J. G.; Palmad, A.;
Vasquez-Medranoc, R. Organic electrosynthesis: a promising green
methodology in organic chemistry. Green Chem. 2010, 12, 2099−2119.
(8) Moeller, K. D. Synthetic applications of anodic electrochemistry.
Tetrahedron 2000, 56, 9527−9554.
(9) Yoshida, J.-I.; Kataoka, K.; Horcajada, R.; Nagaki, A. Modern
strategies in electroorganic synthesis. Chem. Rev. 2008, 108, 2265−
2299.
metabolized compound tolbutamide determined in sandwiched-
cultured rat hepatocytes. Drug Metab. Dispos. 2004, 32, 884−891.
(22) Aumuller, W.; Weyer, R.; Korger, G. Process for the
manufacturing of N-sulphonyl-N′-acyl-ureas. U.S. Patent 3,068,282,
1962.
(23) Moeller, K. D. The electrochemistry of nitrogen containing
compounds. In Encyclopedia of Electrochemistry; Schafer, H. J., Ed.;
̈
Wiley-VCH Verlag GmbH & Co.: Berlin, Germany, 2004; Vol. 8, pp
277−312.
(24) El-Masri, H. A.; Portier, C. J. Physiologically based
pharmacokinetics model of primidone and its metabolites phenobar-
bital and phenylethylmalonamide in humans, rats, and mice. Drug
Metab. Dispos. 1998, 26, 585−594.
(25) Galvao de Lima, R.; Bonato, P. S.; Santana da Silva, R. Analysis
̃
of albendazole metabolites by electrospray LC−MS/MS as a probe to
elucidate electro-oxidation mechanism of albendazole. J. Pharm.
Biomed. 2003, 32, 337−343.
(26) Kitzman, D.; Cheng, K.-J.; Fleckenstein, L. HPLC assay for
albendazole and metabolites in human plasma for clinical pharmaco-
kinetic studies. J. Pharm. Biomed. 2002, 30, 801−13.
(27) Lourenco̧ , T. C.; Batista, J. M.; Furlan, M.; He, Y.; Nafie, L. A.;
Santana, C. C.; Cass, Q. B. Albendazole sulfoxide enantiomers:
preparative chiral separation and absolute stereochemistry. J.
Chromatogr., A 2012, 1230, 61−65.
(28) Curry, S. H. Determination of nanogram quantities of
chlorpromazine and some of its metabolites in plasma using gas-
liquid chromatography with an electron capture detector. Anal. Chem.
1968, 40, 1251−1255.
(29) Salzman, N. P.; Moran, N. C.; Brodie, B. B. Identification and
pharmacological properties of a major metabolite of chlorpromazine.
Nature 1955, 176, 1122−1123.
(30) Madsen, K. G.; Skonberg, C.; Jurva, U.; Cornett, C.; Hansen, S.
H.; Johansen, T. N.; Olsen, J. Bioactivation of diclofenac in vitro and
in vivo: correlation to electrochemical studies. Chem. Res. Toxicol.
2008, 21, 1107−1119.
(10) Horcajada, R.; Okajima, M.; Suga, S.; Yoshida, J. Microflow
electroorganic synthesis without supporting electrolyte. Chem.
Commun. 2005, 1303−1305.
(11) Paddon, C. A.; Pritchard, G. J.; Thiemann, T.; Marken, F. Paired
electrosynthesis: micro-flow cell processes with and without added
electrolyte. Electrochem. Commun. 2002, 4, 825−831.
(12) Horii, D.; Fuchigami, T.; Atobe, M. A new approach to anodic
substitution reaction using parallel laminar flow in a micro-flow
reactor. J. Am. Chem. Soc. 2007, 129, 11692−11693.
(13) Karst, U. Electrochemistry/mass spectrometry (EC/MS): a new
tool to study drug metabolism and reaction mechanisms. Angew.
Chem., Int. Ed. 2004, 43, 2476−2478.
(14) Permentier, H. P.; Bruins, A. P.; Bischoff, R. Electrochemistry-
mass spectrometry in drug metabolism and protein research. Mini-Rev.
Med. Chem. 2008, 8, 46−56.
(15) Roth, G. P.; Stalder, R.; Long, T. R.; Sauer, D. R.; Djuric, S. W.
Continuous-flow microfluidic electrochemical synthesis: investigating a
new tool for oxidative chemistry. J. Flow Chem. 2013, 3, 34−40.
(16) Tang, W.; Stearns, R. A.; Wang, R. W.; Chiu, S. H.; Baillie, T. A.
Roles of human hepatic cytochrome P450s 2C9 and 3A4 in the
metabolic activation of diclofenac. Chem. Res. Toxicol. 1999, 12, 192−
199.
(17) Tang, W. E. I.; Stearns, R. A.; Bandiera, S. M.; Zhang, Y.; Raab,
C.; Braun, M. P.; Dean, D. C.; Pang, J.; Leung, K. H.; Doss, G. A.;
Strauss, J. R.; Kwei, G. Y.; Rushmore, T. H.; Chiu, S. L.; Baillie, T. A.
Studies on cytochrome P450-mediated bioactivation of diclofenac in
rats and in human hepatocytes: identification of glutathione
conjugated metabolites. Drug Metab. Dispos. 1999, 27, 365−372.
(18) Waldon, D. J.; Teffera, Y.; Colletti, A. E.; Liu, J.; Zurcher, D.;
Copeland, K. W.; Zhao, Z. Identification of quinone imine containing
glutathione conjugates of diclofenac in rat bile. Chem. Res. Toxicol.
2010, 23, 1947−1953.
(19) Kenny, J. R.; Maggs, J. L.; Meng, X.; Sinnott, D.; Clarke, S. E.;
Park, B. K.; Stachulski, A. V. Syntheses and characterization of the acyl
glucuronide and hydroxy metabolites of diclofenac. J. Med. Chem.
2004, 47, 2816−2825.
(20) Tozuka, Z.; Aoyama, S.; Nozawa, K.; Akita, S.; Oh-Hara, T.;
Adachi, Y.; Ninomiya, S.-I. Comprehensive quantitative and qualitative
liquid chromatography−radioisotope−mass spectrometry analysis for
safety testing of tolbutamide metabolites without standard samples. J.
Pharm. Sci. 2011, 100, 4024−4036.
(21) Treijtel, N.; Barendregt, A.; Freidig, A. P.; Blaauboer, B. J.; van
Eijkeren, J. C. H. Modeling the in vitro intrinsic clearance of the slowly
1123
dx.doi.org/10.1021/ml400316p | ACS Med. Chem. Lett. 2013, 4, 1119−1123